Is Enlicitide legal in the United States?

The first PCSK9 inhibitor you can swallow. A macrocyclic peptide that cut LDL cholesterol by 57 percent in 2,909 people, in a class that until now required injection.

PCSK9 inhibitors lower LDL cholesterol dramatically and, until 2026, all of them were injections. Enlicitide is a macrocyclic peptide engineered to survive the gut and be absorbed as a once-daily tablet, which is a genuinely hard problem: peptides are normally destroyed by digestion, and its oral bioavailability is around one percent even with an absorption enhancer.

Mechanism: Binds PCSK9 and blocks it from binding the LDL receptor. PCSK9 normally marks LDL receptors for destruction, so inhibiting it leaves more receptors on the liver surface to clear LDL from the blood.

Regulatory history: FDA approved 2026 for lowering LDL cholesterol. Prescription only.

Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.

The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Enlicitide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.